封面
市场调查报告书
商品编码
1888799

干细胞培养基市场规模、份额和趋势分析报告:按细胞类型、应用、最终用途、地区和细分市场预测(2025-2033 年)

Stem Cell Culture Media Market Size, Share & Trends Analysis Report By Cell, By Application, By End-use, By Region, And Segment Forecasts, 2025 - 2033

出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

干细胞培养基市场摘要

2024年全球干细胞培养基市场规模估计为6.724亿美元,预计2033年将达到20.313亿美元。

预计从 2025 年到 2033 年,该行业将以 13.35% 的复合年增长率增长,这主要得益于再生医学的日益普及、干细胞研究的扩展以及对细胞疗法开发投资的增加。

扩大再生医学的应用

再生医学的日益普及是干细胞培养基需求的主要驱动力,因为基于干细胞的治疗方法需要高品质、临床相关的配方来促进细胞生长和生产。神经退化性疾病、心血管疾病、整形外科和自体免疫疾病的日益普遍,推动了间质干细胞(MSCs)、胚胎干细胞(ESCs)、诱导诱导性多功能干细胞(iPSCs)和造血干细胞(HSCs)的研究。这使得学术机构、生技公司和医院越来越依赖无血清、无异种成分且化学成分明确的专用培养基,以确保安全性、一致性和符合监管要求。

干细胞,特别是间质干细胞(MSCs)、胚胎干细胞(ES细胞)和诱导多能干细胞(iPS细胞),正越来越多地被用于慢性疾病的体外建模,从而实现更精准的药物筛检和对疾病机制更深入的理解,进而拓展了干细胞培养基的应用范围。为应对日益增长的医疗负担,公共和私人领域对再生医学的投资不断增加,进一步推动了对高品质、化学成分明确、无异种成分、符合GMP标准的培养基的需求,以支持临床和商业生产。人口压力、科学进步和未被满足的医疗需求共同作用,持续推动全球干细胞培养基产业的发展。

过渡到化学成分明确、不含动物源成分的培养基

市场的主要驱动力是化学成分明确、不含动物源成分的培养基的发展趋势,这主要受监管审查力度加大以及对更安全、更可靠、更可重复的细胞培养系统的需求所驱动。传统培养基中存在的血清和动物源成分会带来免疫抗原性、污染、变异性和伦理问题等风险,促使FDA和EMA等机构倡导去除这些成分。随着干细胞应用逐渐接近临床治疗方法级别,研究人员和生产商正在采用成分明确、不含血清的配方,这些配方能够更好地控制细胞生长和分化,同时满足国际监管机构对成分完全明确且相容的成分的要求。

将化学成分明确、不含异种成分的培养基过渡,使得干细胞产品的生产能够以符合GMP规范的方式进行规模化。随着企业从小小规模研发转向大规模临床生物加工,培养基性能的稳定性和可重复性对于确保治疗品质和获得监管部门的核准至关重要。自动化生物反应器、3D培养系统和类器官平台的应用进一步推动了对可靠、标准化且适用于临床工作流程的培养基的需求。随着生物製药公司、合约研发生产机构(CDMO)和研究机构对先进培养基解决方案的大力投资,对不含异种成分、化学成分明确的培养基的需求正在呈指数级增长。

目录

第一章调查方法和范围

第二章执行摘要

第三章 市场变数与趋势

  • 市场趋势展望
    • 母市场展望
    • 相关及附随市场展望
  • 市场动态
  • 产业分析工具
    • 波特五力分析
    • PESTEL 分析

第四章 细胞业务分析

  • 干细胞培养基市场:细胞变异性分析
  • 间质干细胞(MSCs)
    • 间质干细胞(MSCs)市场,2021-2033年
  • 造血干细胞(HSCs)
    • 造血干细胞(HSC)市场,2021-2033年
  • 诱导性多功能干细胞(iPS细胞)
    • 诱导性多功能干细胞(iPS细胞)市场,2021-2033年
  • 其他干细胞
    • 其他干细胞市场,2021-2033年

第五章:按应用程式进行业务分析

  • 干细胞培养基市场:依应用分類的差异分析
  • 药物发现与开发
    • 药物发现与开发市场,2021-2033年
  • 干细胞疗法生产
    • 干细胞疗法製造市场,2021-2033年
  • 组织工程与再生医学
    • 组织工程与再生医学市场,2021-2033年

第六章 依最终用途进行业务分析

  • 干细胞培养基市场:终端用途差异分析
  • 製药和生物技术公司
    • 2021-2033年医药与生技市场
  • CDMO/CRO
    • CDMO/CRO市场,2021-2033年
  • 干细胞库/生物库
    • 干细胞库/生物库市场,2021-2033年
  • 医院及移植中心
    • 2021-2033年医院及移植中心市场
  • 学术和研究机构
    • 2021-2033年学术与研究机构市场

第七章:区域商业分析

  • 2024 年及 2033 年各地区干细胞培养基市场份额
  • 北美洲
    • 2021-2033年北美干细胞培养基市场
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 2021-2033年欧洲干细胞培养基市场
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 2021-2033年亚太地区干细胞培养基市场
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 泰国
    • 韩国
  • 拉丁美洲
    • 2021-2033年拉丁美洲干细胞培养基市场
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 2021-2033年中东及非洲(MEA)干细胞培养基市场
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争情势

  • 公司分类
  • 策略规划
  • 企业市场分析(2024)
  • 公司简介/列表
    • Thermo Fisher Scientific
    • STEMCELL Technologies
    • Fujifilm Irvine Scientific
    • Merck KGaA
    • Sartorius AG
    • Lonza
    • Miltenyi Biotec
    • Danaher(Cytiva)
    • REPROCELL USA Inc.
    • Takara Bio Inc.
    • PromoCell
Product Code: GVR-4-68040-821-1

Stem Cell Culture Media Market Summary

The global stem cell culture media market size was estimated at USD 672.4 million in 2024 and is projected to reach USD 2,031.3 million by 2033, growing at a CAGR of 13.35% from 2025 to 2033, driven by rising adoption of regenerative therapies, expanding stem-cell-based research, and increasing investments in cell therapy development.

Growing Adoption of Regenerative Medicine

The rising adoption of regenerative medicine is a major driver of demand for stem cell culture media, as stem-cell-based therapies require high-quality, clinically compliant formulations for cell expansion and manufacturing. The growing prevalence of neurodegenerative, cardiovascular, orthopedic, and autoimmune disorders is driving research into MSCs, ESCs, iPSCs, and HSCs, prompting academic institutions, biotech companies, and hospitals to rely increasingly on specialized serum-free, xeno-free, and chemically defined media that ensure safety, consistency, and regulatory compliance.

Stem cells, especially MSCs, ESCs, and iPSCs, are increasingly used to model chronic diseases in vitro, enabling more accurate drug screening and a deeper understanding of disease mechanisms, which broadens the use of stem cell culture media. Growing public and private investment in regenerative medicine to address rising healthcare burdens is further accelerating demand for high-quality, chemically defined, xeno-free, and GMP-grade media to support clinical and commercial manufacturing. Together, demographic pressures, scientific progress, and unmet medical needs continue to strengthen the global stem cell culture media industry.

Shift Toward Chemically Defined & Xeno-Free Media

A major factor propelling the market is the growing trend toward chemically defined and xeno-free stem cell culture media, which is bolstered by heightened regulatory scrutiny and the demand for cell culture systems that are safer, more reliable, and reproducible. Because serum- or animal-derived ingredients in conventional media pose risks such as immunogenicity, contamination, variability, and ethical concerns, organizations like the FDA and EMA are advocating for the elimination of ingredients of animal origin. Researchers and manufacturers are embracing defined, serum-free formulations that provide more control over cell growth and differentiation, while satisfying international regulatory requirements for fully characterized, compliant inputs, as stem cell applications move closer to clinical-grade therapies.

The transition to chemically defined and xeno-free media is also making it possible to scale up production of stem-cell-based products in a way that complies with GMP. Consistent and repeatable media performance is crucial for ensuring therapeutic quality and regulatory approval as businesses transition from small-scale R&D to large-scale clinical bioprocessing. The demand for reliable, standardized media that are tailored for clinical workflows is further increased by the use of automated bioreactors, 3D culture systems, and organoid platforms. The demand for xeno-free, chemically defined formulations is therefore rising sharply as a result of biopharmaceutical companies, CDMOs, and research institutions making significant investments in advanced media solutions.

Global Stem Cell Culture Media Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global stem cell culture media market report based on cell, application, end-use, and region:

  • Cell Outlook (Revenue, USD Million, 2021 - 2033)
  • Mesenchymal Stem Cells (MSCs)
  • Hematopoietic Stem Cells (HSCs)
  • Induced Pluripotent Stem Cells (iPSCs)
  • Other Stem Cells
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Drug Discovery & Development
  • Stem Cell Therapy Manufacturing
  • Tissue Engineering & Regenerative Medicine
  • End-use Outlook (Revenue, USD Million, 2021 - 2033)
  • Pharmaceutical & Biotechnology Companies
  • CDMOs & CROs
  • Stem Cell Banks / Biobanks
  • Hospitals & Transplant Centers
  • Academic & Research Institutes
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
    • Thailand
    • South Korea
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Segment Definitions
  • 1.2. Regional Scope
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Objective
    • 1.4.1. Objective 1
    • 1.4.2. Objective2
    • 1.4.3. Objective 3
  • 1.5. Research Methodology
  • 1.6. Information Procurement
    • 1.6.1. Purchased Database
    • 1.6.2. GVR's Internal Database
    • 1.6.3. Secondary Sources
    • 1.6.4. Primary Research
  • 1.7. Information or Data Analysis:
    • 1.7.1. Data Analysis Models
  • 1.8. Market Formulation & Validation
  • 1.9. Model Details
    • 1.9.1. Commodity Flow Analysis
  • 1.10. List of Secondary Sources
  • 1.11. List of Abbreviations

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables and Trends

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Growing adoption of regenerative medicine
      • 3.2.1.2. Shift toward chemically defined & xeno-free media
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High cost of advanced media formulations
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis

Chapter 4. Cell Business Analysis

  • 4.1. Stem Cell Culture Media Market: Cell Movement Analysis
  • 4.2. Mesenchymal Stem Cells (MSCs)
    • 4.2.1. Mesenchymal Stem Cells (MSCs) Market, 2021 - 2033 (USD Million)
  • 4.3. Hematopoietic Stem Cells (HSCs)
    • 4.3.1. Hematopoietic Stem Cells (HSCs) Market, 2021 - 2033 (USD Million)
  • 4.4. Induced Pluripotent Stem Cells (iPSCs)
    • 4.4.1. Induced Pluripotent Stem Cells (iPSCs) Market, 2021 - 2033 (USD Million)
  • 4.5. Other Stem Cells
    • 4.5.1. Other Stem Cells Market, 2021 - 2033 (USD Million)

Chapter 5. Application Business Analysis

  • 5.1. Stem Cell Culture Media Market: Application Movement Analysis
  • 5.2. Drug Discovery & Development
    • 5.2.1. Drug Discovery & Development Market, 2021 - 2033 (USD Million)
  • 5.3. Stem Cell Therapy Manufacturing
    • 5.3.1. Stem Cell Therapy Manufacturing Market, 2021 - 2033 (USD Million)
  • 5.4. Tissue Engineering & Regenerative Medicine
    • 5.4.1. Tissue Engineering & Regenerative Medicine Market, 2021 - 2033 (USD Million)

Chapter 6. End Use Business Analysis

  • 6.1. Stem Cell Culture Media Market: End Use Movement Analysis
  • 6.2. Pharmaceutical & Biotechnology Companies
    • 6.2.1. Pharmaceutical & Biotechnology Companies Market, 2021 - 2033 (USD Million)
  • 6.3. CDMOs & CROs
    • 6.3.1. CDMOs & CROs Market, 2021 - 2033 (USD Million)
  • 6.4. Stem Cell Banks / Biobanks
    • 6.4.1. Stem Cell Banks / Biobanks Market, 2021 - 2033 (USD Million)
  • 6.5. Hospitals & Transplant Centers
    • 6.5.1. Hospitals & Transplant Centers Market, 2021 - 2033 (USD Million)
  • 6.6. Academic & Research Institutes
    • 6.6.1. Academic & Research Institutes Market, 2021 - 2033 (USD Million)

Chapter 7. Regional Business Analysis

  • 7.1. Stem Cell Culture Media Market Share By Region, 2024 & 2033
  • 7.2. North America
    • 7.2.1. North America Stem Cell Culture Media Market, 2021 - 2033 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1. Key Country Dynamics
      • 7.2.2.2. Regulatory framework
      • 7.2.2.3. Competitive Scenario
      • 7.2.2.4. U.S. Stem Cell Culture Media Market, 2021 - 2033 (USD Million)
    • 7.2.3. Canada
      • 7.2.3.1. Key Country Dynamics
      • 7.2.3.2. Regulatory framework
      • 7.2.3.3. Competitive Scenario
      • 7.2.3.4. Canada Stem Cell Culture Media Market, 2021 - 2033 (USD Million)
    • 7.2.4. Mexico
      • 7.2.4.1. Key Country Dynamics
      • 7.2.4.2. Regulatory framework
      • 7.2.4.3. Competitive Scenario
      • 7.2.4.4. Mexico Stem Cell Culture Media Market, 2021 - 2033 (USD Million)
  • 7.3. Europe
    • 7.3.1. Europe Stem Cell Culture Media Market, 2021 - 2033 (USD Million)
    • 7.3.2. UK
      • 7.3.2.1. Key Country Dynamics
      • 7.3.2.2. Regulatory framework
      • 7.3.2.3. Competitive Scenario
      • 7.3.2.4. UK Stem Cell Culture Media Market, 2021 - 2033 (USD Million)
    • 7.3.3. Germany
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Regulatory framework
      • 7.3.3.3. Competitive Scenario
      • 7.3.3.4. Germany Stem Cell Culture Media Market, 2021 - 2033 (USD Million)
    • 7.3.4. France
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Regulatory framework
      • 7.3.4.3. Competitive Scenario
      • 7.3.4.4. France Stem Cell Culture Media Market, 2021 - 2033 (USD Million)
    • 7.3.5. Italy
      • 7.3.5.1. Key Country Dynamics
      • 7.3.5.2. Regulatory framework
      • 7.3.5.3. Competitive Scenario
      • 7.3.5.4. Italy Stem Cell Culture Media Market, 2021 - 2033 (USD Million)
    • 7.3.6. Spain
      • 7.3.6.1. Key Country Dynamics
      • 7.3.6.2. Regulatory framework
      • 7.3.6.3. Competitive Scenario
      • 7.3.6.4. Spain Stem Cell Culture Media Market, 2021 - 2033 (USD Million)
    • 7.3.7. Denmark
      • 7.3.7.1. Key Country Dynamics
      • 7.3.7.2. Regulatory framework
      • 7.3.7.3. Competitive Scenario
      • 7.3.7.4. Denmark Stem Cell Culture Media Market, 2021 - 2033 (USD Million)
    • 7.3.8. Sweden
      • 7.3.8.1. Key Country Dynamics
      • 7.3.8.2. Regulatory framework
      • 7.3.8.3. Competitive Scenario
      • 7.3.8.4. Sweden Stem Cell Culture Media Market, 2021 - 2033 (USD Million)
    • 7.3.9. Norway
      • 7.3.9.1. Key Country Dynamics
      • 7.3.9.2. Regulatory framework
      • 7.3.9.3. Competitive Scenario
      • 7.3.9.4. Norway Stem Cell Culture Media Market, 2021 - 2033 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific Stem Cell Culture Media Market, 2021 - 2033 (USD Million)
    • 7.4.2. Japan
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Regulatory framework
      • 7.4.2.3. Competitive Scenario
      • 7.4.2.4. Japan Stem Cell Culture Media Market, 2021 - 2033 (USD Million)
    • 7.4.3. China
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Regulatory framework
      • 7.4.3.3. Competitive Scenario
      • 7.4.3.4. China Stem Cell Culture Media Market, 2021 - 2033 (USD Million)
    • 7.4.4. India
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Regulatory framework
      • 7.4.4.3. Competitive Scenario
      • 7.4.4.4. India Stem Cell Culture Media Market, 2021 - 2033 (USD Million)
    • 7.4.5. Australia
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Regulatory framework
      • 7.4.5.3. Competitive Scenario
      • 7.4.5.4. Australia Stem Cell Culture Media Market, 2021 - 2033 (USD Million)
    • 7.4.6. Thailand
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Regulatory framework
      • 7.4.6.3. Competitive Scenario
      • 7.4.6.4. Thailand Stem Cell Culture Media Market, 2021 - 2033 (USD Million)
    • 7.4.7. South Korea
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Regulatory framework
      • 7.4.7.3. Competitive Scenario
      • 7.4.7.4. South Korea Stem Cell Culture Media Market, 2021 - 2033 (USD Million)
  • 7.5. Latin America
    • 7.5.1. Latin America Stem Cell Culture Media Market, 2021 - 2033 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Regulatory framework
      • 7.5.2.3. Competitive Scenario
      • 7.5.2.4. Brazil Stem Cell Culture Media Market, 2021 - 2033 (USD Million)
    • 7.5.3. Argentina
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Regulatory framework
      • 7.5.3.3. Competitive Scenario
      • 7.5.3.4. Argentina Stem Cell Culture Media Market, 2021 - 2033 (USD Million)
  • 7.6. MEA
    • 7.6.1. MEA Stem Cell Culture Media Market, 2021 - 2033 (USD Million)
    • 7.6.2. South Africa
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Regulatory framework
      • 7.6.2.3. Competitive Scenario
      • 7.6.2.4. South Africa Stem Cell Culture Media Market, 2021 - 2033 (USD Million)
    • 7.6.3. Saudi Arabia
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Regulatory framework
      • 7.6.3.3. Competitive Scenario
      • 7.6.3.4. Saudi Arabia Stem Cell Culture Media Market, 2021 - 2033 (USD Million)
    • 7.6.4. UAE
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Regulatory framework
      • 7.6.4.3. Competitive Scenario
      • 7.6.4.4. UAE Stem Cell Culture Media Market, 2021 - 2033 (USD Million)
    • 7.6.5. Kuwait
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Regulatory framework
      • 7.6.5.3. Competitive Scenario
      • 7.6.5.4. Kuwait Stem Cell Culture Media Market, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Position Analysis, 2024
  • 8.4. Company Profiles/Listing
    • 8.4.1. Thermo Fisher Scientific
      • 8.4.1.1. Overview
      • 8.4.1.2. Financial Performance
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Strategic Initiatives
    • 8.4.2. STEMCELL Technologies
      • 8.4.2.1. Overview
      • 8.4.2.2. Financial Performance
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Strategic Initiatives
    • 8.4.3. Fujifilm Irvine Scientific
      • 8.4.3.1. Overview
      • 8.4.3.2. Financial Performance
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Strategic Initiatives
    • 8.4.4. Merck KGaA
      • 8.4.4.1. Overview
      • 8.4.4.2. Financial Performance
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Strategic Initiatives
    • 8.4.5. Sartorius AG
      • 8.4.5.1. Overview
      • 8.4.5.2. Financial Performance
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Strategic Initiatives
    • 8.4.6. Lonza
      • 8.4.6.1. Overview
      • 8.4.6.2. Financial Performance
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Strategic Initiatives
    • 8.4.7. Miltenyi Biotec
      • 8.4.7.1. Overview
      • 8.4.7.2. Financial Performance
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Strategic Initiatives
    • 8.4.8. Danaher (Cytiva)
      • 8.4.8.1. Overview
      • 8.4.8.2. Financial Performance
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Strategic Initiatives
    • 8.4.9. REPROCELL USA Inc.
      • 8.4.9.1. Overview
      • 8.4.9.2. Financial Performance
      • 8.4.9.3. Product Benchmarking
      • 8.4.9.4. Strategic Initiatives
    • 8.4.10. Takara Bio Inc.
      • 8.4.10.1. Overview
      • 8.4.10.2. Financial Performance
      • 8.4.10.3. Product Benchmarking
      • 8.4.10.4. Strategic Initiatives
    • 8.4.11. PromoCell
      • 8.4.11.1. Overview
      • 8.4.11.2. Financial Performance
      • 8.4.11.3. Product Benchmarking
      • 8.4.11.4. Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Regulatory Framework
  • Table 4 Global Stem Cell Culture Media Market, By Cell, 2021 - 2033 (USD Million)
  • Table 5 Global Stem Cell Culture Media Market, By Application, 2021 - 2033 (USD Million)
  • Table 6 Global Stem Cell Culture Media Market, By End Use, 2021 - 2033 (USD Million)
  • Table 7 Global Stem Cell Culture Media Market, By Region, 2021 - 2033 (USD Million)
  • Table 8 North America Stem Cell Culture Media Market, By Country, 2021 - 2033 (USD Million)
  • Table 9 North America Stem Cell Culture Media Market, By Cell, 2021 - 2033 (USD Million)
  • Table 10 North America Stem Cell Culture Media Market, By Application, 2021 - 2033 (USD Million)
  • Table 11 North America Stem Cell Culture Media Market, By End Use, 2021 - 2033 (USD Million)
  • Table 12 U.S. Stem Cell Culture Media Market, By Cell, 2021 - 2033 (USD Million)
  • Table 13 U.S. Stem Cell Culture Media Market, By Application, 2021 - 2033 (USD Million)
  • Table 14 U.S. Stem Cell Culture Media Market, By End Use, 2021 - 2033 (USD Million)
  • Table 15 Canada Stem Cell Culture Media Market, By Cell, 2021 - 2033 (USD Million)
  • Table 16 Canada Stem Cell Culture Media Market, By Application, 2021 - 2033 (USD Million)
  • Table 17 Canada Stem Cell Culture Media Market, By End Use, 2021 - 2033 (USD Million)
  • Table 18 Mexico Stem Cell Culture Media Market, By Cell, 2021 - 2033 (USD Million)
  • Table 19 Mexico Stem Cell Culture Media Market, By Application, 2021 - 2033 (USD Million)
  • Table 20 Mexico Stem Cell Culture Media Market, By End Use, 2021 - 2033 (USD Million)
  • Table 21 Europe Stem Cell Culture Media Market, By Country, 2021 - 2033 (USD Million)
  • Table 22 Europe Stem Cell Culture Media Market, By Cell, 2021 - 2033 (USD Million)
  • Table 23 Europe Stem Cell Culture Media Market, By Application, 2021 - 2033 (USD Million)
  • Table 24 Europe Stem Cell Culture Media Market, By End Use, 2021 - 2033 (USD Million)
  • Table 25 UK Stem Cell Culture Media Market, By Cell, 2021 - 2033 (USD Million)
  • Table 26 UK Stem Cell Culture Media Market, By Application, 2021 - 2033 (USD Million)
  • Table 27 UK Stem Cell Culture Media Market, By End Use, 2021 - 2033 (USD Million)
  • Table 28 Germany Stem Cell Culture Media Market, By Cell, 2021 - 2033 (USD Million)
  • Table 29 Germany Stem Cell Culture Media Market, By Application, 2021 - 2033 (USD Million)
  • Table 30 Germany Stem Cell Culture Media Market, By End Use, 2021 - 2033 (USD Million)
  • Table 31 France Stem Cell Culture Media Market, By Cell, 2021 - 2033 (USD Million)
  • Table 32 France Stem Cell Culture Media Market, By Application, 2021 - 2033 (USD Million)
  • Table 33 France Stem Cell Culture Media Market, By End Use, 2021 - 2033 (USD Million)
  • Table 34 Spain Stem Cell Culture Media Market, By Cell, 2021 - 2033 (USD Million)
  • Table 35 Spain Stem Cell Culture Media Market, By Application, 2021 - 2033 (USD Million)
  • Table 36 Spain Stem Cell Culture Media Market, By End Use, 2021 - 2033 (USD Million)
  • Table 37 Italy Stem Cell Culture Media Market, By Cell, 2021 - 2033 (USD Million)
  • Table 38 Italy Stem Cell Culture Media Market, By Application, 2021 - 2033 (USD Million)
  • Table 39 Italy Stem Cell Culture Media Market, By End Use, 2021 - 2033 (USD Million)
  • Table 40 Denmark Stem Cell Culture Media Market, By Cell, 2021 - 2033 (USD Million)
  • Table 41 Denmark Stem Cell Culture Media Market, By Application, 2021 - 2033 (USD Million)
  • Table 42 Denmark Stem Cell Culture Media Market, By End Use, 2021 - 2033 (USD Million)
  • Table 43 Norway Stem Cell Culture Media Market, By Cell, 2021 - 2033 (USD Million)
  • Table 44 Norway Stem Cell Culture Media Market, By Application, 2021 - 2033 (USD Million)
  • Table 45 Norway Stem Cell Culture Media Market, By End Use, 2021 - 2033 (USD Million)
  • Table 46 Sweden Stem Cell Culture Media Market, By Cell, 2021 - 2033 (USD Million)
  • Table 47 Sweden Stem Cell Culture Media Market, By Application, 2021 - 2033 (USD Million)
  • Table 48 Sweden Stem Cell Culture Media Market, By End Use, 2021 - 2033 (USD Million)
  • Table 49 Asia Pacific Stem Cell Culture Media Market, By Country, 2021 - 2033 (USD Million)
  • Table 50 Asia Pacific Stem Cell Culture Media Market, By Cell, 2021 - 2033 (USD Million)
  • Table 51 Asia Pacific Stem Cell Culture Media Market, By Application, 2021 - 2033 (USD Million)
  • Table 52 Asia Pacific Stem Cell Culture Media Market, By End Use, 2021 - 2033 (USD Million)
  • Table 53 China Stem Cell Culture Media Market, By Cell, 2021 - 2033 (USD Million)
  • Table 54 China Stem Cell Culture Media Market, By Application, 2021 - 2033 (USD Million)
  • Table 55 China Stem Cell Culture Media Market, By End Use, 2021 - 2033 (USD Million)
  • Table 56 Japan Stem Cell Culture Media Market, By Cell, 2021 - 2033 (USD Million)
  • Table 57 Japan Stem Cell Culture Media Market, By Application, 2021 - 2033 (USD Million)
  • Table 58 Japan Stem Cell Culture Media Market, By End Use, 2021 - 2033 (USD Million)
  • Table 59 India Stem Cell Culture Media Market, By Cell, 2021 - 2033 (USD Million)
  • Table 60 India Stem Cell Culture Media Market, By Application, 2021 - 2033 (USD Million)
  • Table 61 India Stem Cell Culture Media Market, By End Use, 2021 - 2033 (USD Million)
  • Table 62 South Korea Stem Cell Culture Media Market, By Cell, 2021 - 2033 (USD Million)
  • Table 63 South Korea Stem Cell Culture Media Market, By Application, 2021 - 2033 (USD Million)
  • Table 64 South Korea Stem Cell Culture Media Market, By End Use, 2021 - 2033 (USD Million)
  • Table 65 Australia Stem Cell Culture Media Market, By Cell, 2021 - 2033 (USD Million)
  • Table 66 Australia Stem Cell Culture Media Market, By Application, 2021 - 2033 (USD Million)
  • Table 67 Australia Stem Cell Culture Media Market, By End Use, 2021 - 2033 (USD Million)
  • Table 68 Thailand Stem Cell Culture Media Market, By Cell, 2021 - 2033 (USD Million)
  • Table 69 Thailand Stem Cell Culture Media Market, By Application, 2021 - 2033 (USD Million)
  • Table 70 Thailand Stem Cell Culture Media Market, By End Use, 2021 - 2033 (USD Million)
  • Table 71 Latin America Stem Cell Culture Media Market, By Country, 2021 - 2033 (USD Million)
  • Table 72 Latin America Stem Cell Culture Media Market, By Cell, 2021 - 2033 (USD Million)
  • Table 73 Latin America Stem Cell Culture Media Market, By Application, 2021 - 2033 (USD Million)
  • Table 74 Latin America Stem Cell Culture Media Market, By End Use, 2021 - 2033 (USD Million)
  • Table 75 Brazil Stem Cell Culture Media Market, By Cell, 2021 - 2033 (USD Million)
  • Table 76 Brazil Stem Cell Culture Media Market, By Application, 2021 - 2033 (USD Million)
  • Table 77 Brazil Stem Cell Culture Media Market, By End Use, 2021 - 2033 (USD Million)
  • Table 78 Argentina Stem Cell Culture Media Market, By Cell, 2021 - 2033 (USD Million)
  • Table 79 Argentina Stem Cell Culture Media Market, By Application, 2021 - 2033 (USD Million)
  • Table 80 Argentina Stem Cell Culture Media Market, By End Use, 2021 - 2033 (USD Million)
  • Table 81 MEA Stem Cell Culture Media Market, By Country, 2021 - 2033 (USD Million)
  • Table 82 MEA Stem Cell Culture Media Market, By Cell, 2021 - 2033 (USD Million)
  • Table 83 MEA Stem Cell Culture Media Market, By Application, 2021 - 2033 (USD Million)
  • Table 84 MEA Stem Cell Culture Media Market, By End Use, 2021 - 2033 (USD Million)
  • Table 85 South Africa Stem Cell Culture Media Market, By Cell, 2021 - 2033 (USD Million)
  • Table 86 South Africa Stem Cell Culture Media Market, By Application, 2021 - 2033 (USD Million)
  • Table 87 South Africa Stem Cell Culture Media Market, By End Use, 2021 - 2033 (USD Million)
  • Table 88 UAE Stem Cell Culture Media Market, By Cell, 2021 - 2033 (USD Million)
  • Table 89 UAE Stem Cell Culture Media Market, By Application, 2021 - 2033 (USD Million)
  • Table 90 UAE Stem Cell Culture Media Market, By End Use, 2021 - 2033 (USD Million)
  • Table 91 Saudi Arabia Stem Cell Culture Media Market, By Cell, 2021 - 2033 (USD Million)
  • Table 92 Saudi Arabia Stem Cell Culture Media Market, By Application, 2021 - 2033 (USD Million)
  • Table 93 Saudi Arabia Stem Cell Culture Media Market, By End Use, 2021 - 2033 (USD Million)
  • Table 94 Kuwait Stem Cell Culture Media Market, By Cell, 2021 - 2033 (USD Million)
  • Table 95 Kuwait Stem Cell Culture Media Market, By Application, 2021 - 2033 (USD Million)
  • Table 96 Kuwait Stem Cell Culture Media Market, By End Use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Stem cell culture media market segmentation
  • Fig. 2 Data analysis models
  • Fig. 3 Market formulation and validation
  • Fig. 4 Data validating & publishing
  • Fig. 5 Market research process
  • Fig. 6 Information procurement
  • Fig. 7 Primary research
  • Fig. 8 Value-chain-based sizing & forecasting
  • Fig. 9 QFD modelling for market share assessment
  • Fig. 10 Market formulation & validation
  • Fig. 11 Commodity flow analysis
  • Fig. 12 Market outlook
  • Fig. 13 Segment snapshot
  • Fig. 14 Competitive landscape snapshot
  • Fig. 15 Market trends & outlook
  • Fig. 16 PESTEL analysis
  • Fig. 17 Porter's five forces analysis
  • Fig. 18 Stem cell culture media market: Cell outlook & key takeaways
  • Fig. 19 Stem cell culture media market: Cell movement analysis
  • Fig. 20 Mesenchymal Stem Cells (MSCs), 2021 - 2033 (USD million)
  • Fig. 21 Hematopoietic Stem Cells (HSCs), 2021 - 2033 (USD million)
  • Fig. 22 Induced Pluripotent Stem Cells (iPSCs), 2021 - 2033 (USD million)
  • Fig. 23 Other stem cells, 2021 - 2033 (USD million)
  • Fig. 24 Stem cell culture media market: Application outlook key takeaways
  • Fig. 25 Stem cell culture media market: Application movement analysis
  • Fig. 26 Drug discovery & development, 2021 - 2033 (USD million)
  • Fig. 27 Stem cell therapy manufacturing, 2021 - 2033 (USD million)
  • Fig. 28 Tissue engineering & regenerative medicine, 2021 - 2033 (USD million)
  • Fig. 29 Stem cell culture media market: End Use Outlook key takeaways
  • Fig. 30 Stem cell culture media market: End Usemovement analysis
  • Fig. 31 Pharmaceutical & Biotechnology Companies, 2021 - 2033 (USD million)
  • Fig. 32 CDMOs & CROs, 2021 - 2033 (USD million)
  • Fig. 33 Stem Cell Banks / Biobanks, 2021 - 2033 (USD million)
  • Fig. 34 Hospitals & Transplant Centers, 2021 - 2033 (USD million)
  • Fig. 35 Academic & Research Institutes, 2021 - 2033 (USD million)
  • Fig. 36 Regional outlook
  • Fig. 37 Regional marketplace: Key takeaways
  • Fig. 38 North America stem cell culture media market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 39 Key country dynamics
  • Fig. 40 US stem cell culture media market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 Key country dynamics
  • Fig. 42 Canada stem cell culture media market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 43 Key country dynamics
  • Fig. 44 Mexico stem cell culture media market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 45 Europe stem cell culture media market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 46 Key country dynamics
  • Fig. 47 Germany stem cell culture media market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 48 Key country dynamics
  • Fig. 49 UK stem cell culture media market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 50 Key country dynamics
  • Fig. 51 France stem cell culture media market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 52 Key country dynamics
  • Fig. 53 Italy stem cell culture media market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 54 Key country dynamics
  • Fig. 55 Spain stem cell culture media market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 56 Key country dynamics
  • Fig. 57 Denmark stem cell culture media market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 58 Key country dynamics
  • Fig. 59 Sweden stem cell culture media market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 60 Key country dynamics
  • Fig. 61 Norway stem cell culture media market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 62 Asia Pacific stem cell culture media market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 63 Key country dynamics
  • Fig. 64 Japan stem cell culture media market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 65 Key country dynamics
  • Fig. 66 China stem cell culture media market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 67 Key country dynamics
  • Fig. 68 India stem cell culture media market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 69 Key country dynamics
  • Fig. 70 Australia stem cell culture media market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 71 Key country dynamics
  • Fig. 72 Thailand stem cell culture media market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 73 Key country dynamics
  • Fig. 74 South Korea stem cell culture media market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 75 Latin America stem cell culture media market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 76 Key country dynamics
  • Fig. 77 Brazil stem cell culture media market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 78 Key country dynamics
  • Fig. 79 Argentina stem cell culture media market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 80 MEA stem cell culture media market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 81 Key country dynamics
  • Fig. 82 South Africa stem cell culture media market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 83 Key country dynamics
  • Fig. 84 Saudi Arabia stem cell culture media market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 85 Key country dynamics
  • Fig. 86 UAE stem cell culture media market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 87 Key country dynamics
  • Fig. 88 Kuwait stem cell culture media market estimates and forecasts, 2021 - 2033 (USD Million)